The Medical Research Commercialisation Fund (MRCF) was established in  2007 and is a collaboration among Australia’s major  superannuation funds, Australia’s leading medical research institutes and research hospitals. MRCF has secured a total of $380 million over three separate funding rounds in investment capital.

All rounds, running from 2007 through to 2022,have been supported on behalf of the WA State Government by the Department of Jobs, Tourism, Science and Innovation (JTSI) together with the Department of Health.

The WA State government’s financial support has led to access to substantial investment in two of the State’s medical companies with a commitment of $26 million, subject to milestones, in the past two years.

This has led to 22 jobs being created in the newly established companies of OncoRes and Respirion

Medical Research Commercialisation Fund (MRCF)

Pictured-Christine, Isobel, Ruby and Gerald Donaldson – The family of two girls with cystic fibrosis are hopeful after Telethon Kids Institute spin-off company, Respirion, receives $20 million in funding to develop a promising new therapy

OncoRes Medical

OncoRes Medical is an intraoperative imaging technology company that assesses the completeness of tumour removal during surgery. The company won the Global Entrepreneur of the Year 2018 in the Pitch@Palace competition that was held at St James Palace, London on December 12, 2018.

The award provides access to a network of potential investors and will be valuable for Series B fundraising.

Respirion Pharmaceuticals

Founded in 2018, Respirion Pharmaceuticals is an early-stage biotechnology company focused on developing new treatments for respiratory disease.  The company is a spinoff  of the Telethon Kids Institute (TKI)  where the technology was developed. The company is developing the technology both in Australia and in the United States.

Telethon Kids Institute Announcement

For further information please contact: Dr Helga Mikkelsen, Investment Analyst at Brandon Capital who manages the MRCF.

Ph:  0491 277 662

Also in this section